Outcome Selection for Research Studies in Movement Disorders

Affiliations

¹ University of Toronto, Movement Disorder Clinic, Edmond J Safra Program in Parkinson Disease, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.

Susan H Fox. Mov Disord Clin Pract. 2024 Dec.

. 2024 Dec;11 Suppl 3(Suppl 3):S26-S30.

doi: 10.1002/mdc3.14087. Epub 2024 Jun 3.

¹ University of Toronto, Movement Disorder Clinic, Edmond J Safra Program in Parkinson Disease, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.

No abstract available

Keywords: clinical trials; outcome measures; primary outcome measures; secondary outcome measures.

References

1. Regnault A, Boroojerdi B, Meunier J, Bani M, Morel T, Cano S. Does the MDS‐UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort. J Neurol 2019;266:1927–1936. - PMC - PubMed
1. Evers LJW, Krijthe JH, Meinders MJ, Bloem BR, Heskes TM. Measuring Parkinson's disease over time: the real‐world within‐subject reliability of the MDS‐UPDRS. Mov Disord 2019;34(10):1480–1487. - PMC - PubMed
1. Hauser RA, Friedlander J, Zesiewicz TA, et al. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia. Clin Neuropharmacol 2000;23:75–81. - PubMed
1. Colosimo C, Martínez‐Martín P, Fabbrini G, et al. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations. Mov Disord 2010;25(9):1131–1142. - PubMed
1. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23(15):2129–2170. - PubMed